Develops cell therapies for cancer and autoimmune diseases.
Jun 2026Revenue $2.80M/yrExpenses $25.0M/yr
No trendCash runway ≈ 1.8 years from Jun 2026
Figures by year
When will Z Squared be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $2.80M and expenses $25.0M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.36M | $14.4M | −$13.0M |
| Dec 2024 | $0.00 | $10.1M | −$10.1M |
| Dec 2023 | $0.00 | $21.5M | −$21.5M |
| Dec 2022 | $0.00 | $34.2M | −$34.2M |
| Dec 2021 | $75.0K | $14.1M | −$14.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.